My watch list  

51 Current news of Carl Zeiss


You can refine your search further. Select from the filter options on the left to narrow down your results.

Carl Zeiss Meditec Remains on Growth Course

Revenues increased by 17.1 percent over previous year


Carl Zeiss Meditec is continuing its successful path in the 2010/11 fiscal year and has increased both revenues and earnings. All three strategic business units (SBU) and reporting regions have contributed to this positive trend."After the first half of our fiscal year, we remain optimistic and ...


Carl Zeiss Meditec makes successful start to financial year 2010/2011

Revenue is 18.6% higher than in previous year


Carl Zeiss Meditec has made a successful start to the new financial year 2010/2011 (as of 31 December 2010). Revenue and earnings increased further in comparison with the same period of the previous year. The positive development of earnings was driven significantly by the strategic business ...


Another Patent Licensed for PAL-M Super-resolution Technology


The United States Patent and Trademark Office has granted Dr. Eric Betzig and Dr. Harald Hess another patent for their invention of super- resolution localization microscopy. In 2007, the microscopy from Carl Zeiss received the exclusive rights to market the technology.Together with the ...


Carl Zeiss Meditec clearly on growth course


With a 20 percent increase in revenue in the third quarter compared with the same quarter of the previous year, Carl Zeiss Meditec generated a very solid result and is thus clearly on a growth course. The Company grew by a total of 3 percent in the first nine months of financial year 2009/2010, ...


2011: Changes in the Carl Zeiss Executive Board

Dr. Dieter Kurz hands over his office as CEO to Dr. Michael Kaschke on 1 January 2011


At its meeting of 24 June 2010 the Supervisory Board of Carl Zeiss AG passed a unanimous resolution concerning personnel changes in the Executive Board. As planned, President and CEO of Carl Zeiss AG, Dr. Dieter Kurz, will not renew his contract that is due to expire at the end of 2010. Dr. ...


Significant Advance in Breast Cancer Therapy

Clinical effectiveness of single, targeted intraoperative radiotherapy (TARGIT) with INTRABEAM proven by study - clear benefits for patients


Reduction of the duration of radiotherapy to one day and gentler treatment overall have now been clinically proven as benefits for breast cancer patients of a single course of targeted intraoperative radiotherapy with INTRABEAM® from Carl Zeiss Meditec. The procedure therefore has the potential ...


Carl Zeiss Ltd. acquires Imaging Associates Ltd.


Carl Zeiss Ltd has agreed to acquire Imaging Associates Ltd. as part of its continuing investment into customer support and service delivery. Imaging Associates (IMAS) has been supporting digital imaging platforms in research, clinical and industrial environments and distributing the Carl Zeiss ...


Dr. Ludwin Monz becomes CEO of Carl Zeiss Meditec


Dr. Ludwin Monz is the new CEO of Carl Zeiss Meditec. He takes over from Dr. Michael Kaschke. At the Annual General Meeting, Kaschke was elected back to the Supervisory Board and was appointed its Chairman in the subsequent Supervisory Board meeting. Dr. Ludwin Monz has been a member of Carl ...


Carl Zeiss Meditec affirms growth target for financial year 2009/2010, despite cautious start


The medical technology company has ended the first quarter of financial year 2009/2010 (balance sheet date: 31 December 2009) with sound results, proving it is able to hold its own in the persistently volatile and difficult economic environment. This steady development is also driven by the ...


Carl Zeiss and the University of California, San Francisco, agree on marketing rights for superresolution microscopy techniques


Carl Zeiss MicroImaging GmbH has received a license from the University of California for the commercialization of “superresolution”, a microscopy technique offering extraordinarily high resolution. The technique called Structured Illumination Microscopy (SIM) was developed by scientists Mats ...


Page 5 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE